Nosocomial infections with enterococci are an increasing problem in modern medical practice due to the development of resistance to a wide range of antibiotics, including the glycopeptides vancomycin and teicoplanin. An increasing number of vancomycinresistant enterococci (VRE) have been cultured from clinical specimens -especially from patients undergoing immunosuppressive therapy -and bacteraemia caused by these VRE, subsequent to colonisation of epithelial surfaces, is a significant cause of mortality in such patients. Recent evidence showed that the induction of indoleamine 2,3 dioxygenase (IDO) by interferon-y (IFN-y) inhibited growth of group B streptococci by depleting the essential amino acid L-tryptophan. This study describes the IFN-y-induced expression of I D 0 -shown at a transcriptional level by Northern blot analysis, at translational level by Western blot and also at a functional level by L-tryptophan degradation to L-kynurenine -in the uro-epithelial cell line RT4. The depletion of Ltryptophan resulted in growth inhibition of enterococci, and this was confirmed by abrogation of the inhibitory effect by re-supplementation with excess L-tryptophan. Multiresistant enterococci, including vancomycin-resistant strains resistant to all commercially available antibiotics, were inhibited by the IFN-y-induced expression of I D 0 and subsequent L-tryptophan degradation. This may be an important mechanism in the local restriction of colonisation of the urinary tract by endogenous enterococci and in inhibiting the spread of the bacteria beyond the epithelial barrier.
Introduction
Enterococci, as part of the gut flora, have classically been involved in infections of the urinary tract, wound infections and infections involving contamination by intestinal contents. Enterococci can also cause more serious infections such as infectious endocarditis and with the emergence of multiresistant enterococci (MRE), infections -especially those occurring in immunocompromised patients -carry a greater morbidity [I] . There have been several reports of vancomycin-resistant enterococcal (VRE) species found in immunocompromised patients which are resistant to all available antibiotics and various combinations thereof [2, 3] . As these multiresistant strains appear to be found in the community [4] , possibly as a result of the use of antibiotics in animal feeds [5, 6] , and as selection takes place in the hospital setting under broad-spectrum antibiotic therapy [7] , it is likely that a certain proportion of patients undergoing immunosuppressive therapy will develop infections due to these organisms. The local containment of infections due to multiresistant organisms may have a significant effect on patient survival, as it has been reported that bacteraemia with VRE is associated with a poorer prognosis in liver transplant patients than bacteraemia with vancomycin-susceptible enterococci [ 81. As antibiotic therapy is unable to contain bacterial growth and prevent dissemination of infection by VRE it is of interest to identify immune mechanisms that suppress local bacterial growth. Enterococci, both sensitive and resistant to antibiotics, can be found as part of the normal flora of man and animals, and presumably there is a balance in numbers between multiresistant strains and sensitive strains until selective pressure for resistance, such as broad-spectrum antibiotic therapy, is present. Colonisation of epithelial surfaces and mucous membranes may precede infection, as may be the case in urinary tract infections (UTI). In some instances, especially where foreign bodies such as urinary catheters are present, these infections may be asymptomatic. Progression to disseminated infection may take place if unchecked proliferation of bacteria occurs, especially in patients with mucosal and epithelial damage caused by chemotherapy. The innate immune defence exerted at and by the mucosal/epithelial surface is also especially important in leukopenic patients, as the major portion of the immune system is functionally absent.
The L-tryptophan degrading enzyme indoleamine 2,3 dioxygenase (IDO) can be induced by interferon-y (IFN-y) in human cells [9] , and a recent study showed that IFN-y-activated human cord blood macrophages inhibited the growth of group B streptococci (GBS) [lo] . This antibacterial effect is extracellular and, therefore, also applicable to non-phagocytic cells that are able to respond to IFN-y by induction of ID0 expression. As such cells may be found in abundance in the endothelium and muco-epithelial surfaces of the body and can also express large amounts of ID0 when stimulated by IFN-y, the present study tested the hypothesis that the non-phagocytic, human uro-epithelial cell line RT4 can be stimulated by IFN-y to express ID0 and that IFN-y-activated RT4 cells are able to inhibit the growth of MRE. It also sought to determine the mechanism involved in this inhibitory effect.
Materials and methods

Bacteria and culture media
Bacterial strains were isolated from patient specimens received for diagnostic tests. The year of isolation as well as the site and corresponding clinical data are detailed in Table 1 . Ten isolates were obtained from routine stool specimens from otherwise healthy persons. Other isolates were obtained from clinically significant specimens as indicated in Table 1 . The Table 1 . Enterococcal species studied organisms were identified by colony characteristics and agglutination with the Strep Plus diagnostic kit (Oxoid) and identified to species level biochemically (API20-STREP, bioMbrieux). All bacteria were grown on Brain Heart Infusion Agar (Difco, Hamburg, Germany) containing sheep blood 5% and incubated at 37°C in a CO2 5% enriched atmosphere. Antibiotic sensitivity was tested by a standardised agar difision method with commercially available antibiotic-containing disks and checked against the Enterococcus faecalis type strain (ATCC 49474). The antibiotic sensitivity of VRE strains was confirmed by a vancomycin macro-dilution test. Before adding the bacteria to the cell cultures, a single colony was picked and resuspended in RPMI medium (without L-glutamine or L-tryptophan) (Seromed, Berlin). Between 10 and 50 bacteria/well were added to cell cultures. The number of cfu was calculated by serially diluting the bacteria in RPMI medium, plating 10 pl of the bacterial suspension on agar plates and counting the colonies after incubation for 18-24 h.
Cell lines and culture
Iscove's modified Dulbecco's medium and RPMI 1640 (Gibco, Grand Island, NY, USA) with and without Ltryptophan were supplemented with 2 n~ L-glutamine and fetal calf serum (FCS) 5% and used as culture media for the cells. FCS was heat-inactivated at 56°C for 45 min before use. The human uro-epithelial carcinoma cell line RT4 was originally obtained from ATCC (Rockville, MA, USA). The cells were cultured in tissue-culture flasks (Costar, Cambridge, MA, USA) in medium as described above and passaged weekly by detaching the adherent cells with trypsin/EDTA (Gibco). Cells for experiments were harvested with trypsin/EDTA, seeded into wells of a 96-well tissueculture plate (Greiner, Solingen, Germany) at a concentration of 3 X 104/well and incubated at 37°C in a humidified atmosphere enriched with CO2 5%.
. . . and transferred to a nylon membrane (Hybond N+, Amersham). The membrane was incubated in Church buffer for 10 min at 65°C and then hybridised with digoxigenin-labelled DNA probes (Boehringer-Mannheim, Germany) specific for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1 0 ng/ml) and for ID0 (20ng/ml) overnight at 65°C. The hybridised labelled probes were detected with the DIG Luminescent Kit for Nucleic Acids from Boehringer-Mannheim following the manufacturer's instructions. The membrane was incubated with the substrate CPD-Star (Boehringer-Mannheim) and then exposed to Kodak X-Omat film to visualise the bands. For Western blot analysis, RT4 cells were stimulated as above and harvested with a cell scraper. The cells were lysed and subjected to electrophoresis on a polyacrylamide 9% gel under denaturing and reducing conditions. The proteins were transferred to nitrocellulose with a semidry electroblotting apparatus (Phase, Molln, Germany).
The membrane was incubated in skim milk 5% in PBS for 1 h at room temperature and thereafter incubated for 1 h with IDO-specific mouse monoclonal antibodies (kindly given by Osamu Takikawa, University of Wollongong, NSW, Australia). The membrane was washed and then incubated for 1 h with goat antimouse IgG-horseradish peroxidase conjugated antibodies (Dianova, Hamburg, Germany). Detection was performed with the ECL kit from Amersham and the membrane was exposed to a Kodak X-Omat film.
Stimulation of RT4 cells and infection with bacteria
IFN-y was kindly donated by Dr M. Hundgen (Rentschler, Laupenheim, Germany). RT4 cells in triplicate wells were stimulated with IFN-y at 150 U/ml or in a 1 to 2 serial dilution starting at 150 U/ml. Cells not stimulated with IFN-y were used as a negative control. The cells were incubated for 96 h, then the bacteria were added. Bacteria were resuspended in WMI medium without L-glutamine or L-tryptophan to reach an end concentration between 1000 and 5000 cfb/ml and added to the wells in 10-p1 volumes, c. 50 bacteria/well; in addition, some cells received L-tryptophan to a final concentration of 100 pg/ml immediately after the inoculation with bacteria. After incubation of cells for 18-24 h, bacterial growth was detected by measuring the optical density at 620 nm. Stimulation of the RT4 cells induces the expression of IDO, which results in the degradation of L-tryptophan. This degradation is almost complete and levels of L-tryptophan are below the detection level of a sensitive HPLC method used in a previous study to measure ID0 activity [ 1 I] . To prove the relationship between enterococcal growth inhibition and L-tryptophan starvation, some IFN-y-stimulated cell cultures were infected with bacteria in medium containing an excess of L-tryptophan, so that the final concentration of L-tryptophan was 100 pg/ml.
Assay of ID0 induction
Parallel RT4 cultures were similarly stimulated with IFN-y and after incubation for 96 h the ID0 induction was measured by a method described previously which detects the presence of L-kynurenine [ 121. Briefly, 160 pl of supernate of the stimulated monocyte-derived macrophages (MDM) were transferred to a V-bottomed 96-well plate (Greiner). Thereafter, 10 pl of trichloracetic acid 30%v/v were added and the supernate was incubated at 50°C in a water bath for 30 min. The precipitated protein was pelleted by centrifugation at 1800 rpm for 10 min and then 100 pl of the resulting supernate were transferred to a flat-bottomed 96-well plate containing 100 p1 of Ehrlichs reagent 1.2% w/v in glacial acetic acid (Sigma) per well. The optical density of the resulting yellow colour change was measured by a photometer (SLT Labinstruments, Crailsheim, Germany) at 492 nm.
Northern and Western blot analysis
RT4 cells were grown in tissue-culture flasks (Costar) and some were stimulated with 400 U of IFN-y/ml for 16-18 h. Thereafter the cells were washed twice with phosphate-buffered saline (PBS) and total cellular RNA was prepared by guanidinium thiocyanate lysis and ultra-centrifugation according to the method described by Sambrook et al. [13] . RNA (70 pg/lane) was separated on an agarose 0.8% formaldehyde 6% gel
Results
IFN-y-induced I D 0 activity in human uroepithelial cells
RT4 cells stimulated with IFN-y 400 U/ml were shown to express ID0 activity at both the translational and transcriptional level. 
Inhibition of enterococcal growth by RT4 cells
As can be seen from Fig. 2 , unstimulated uro-epithelial cell cultures permitted uninhibited growth of the enterococci, whereas the IFN-y-stimulated cells almost completely inhibited the bacterial growth. In Fig. 2 the background OD of the cell cultures without added bacteria was c. 0.145. This bacteriostatic effect was dose-dependent and, as depicted in Fig. 3 , a concentration of IFN-y of 36 U/ml was sufficient to block enterococcal growth in the cell cultures completely. Fig. 3 shows typical results for isolates representative of the three different enterococcal species most commonly isolated from patients with UTI. Fig. 2 shows the growth inhibitory effect of the RT4 cells on these multiresistant strains. Both the multiresistant strains and the VRE were equally inhibited by the RT4 cell cultures after stimulation with IFN-y. Of the 15 strains shown in Fig. 2 , 11 strains were VRE. Thus the uro-epithelial cell line RT4 has a potent inhibitory effect on the growth of clinical enterococcal isolates that are resistant to all commercially available antibiotics.
Fig. 4 shows that supplementing with L-tryptophan abrogated the growth inhibitory effect of the IFN-yinduced IDO, indicating that this effect was due to Ltryptophan depletion. The isolates in Fig. 4 are representative of vancomycin-sensitive and vancomycinresistant isolates.
Discussion
The innate immune system consists of many components that have either a specialised immune function, such as granulocytes and macrophages, or nonspecialised functions such as the creation of an environment unsuitable for organism adherence, invasion and proliferation. Epithelial cells at the very least present a physical barrier to would-be invading organisms and in addition have a strongly inducible ID0 activity [ 141. It has been shown that GBS are able to invade epithelial cells and possibly cause disseminated infection via this route [ 15, 161 . Enterococci causing a UTI must first adhere to the epithelial surface, where inflammation occurs. Invasion of the cell may lead to dissemination and sepsis [16] . Containment of an infection at this stage has obvious advantages for the host. Recruitment of resident macrophages and dendritic cells results in the release of tumour necrosis factor-a, thereby stimulating the local natural killer cells to produce IFN-y. This IFN-y would have stimulating effect on the cells at the local site of infection. The epithelial cells stimulated by IFN-y can express ID0 and thus degrade both intracellular and extracellular L-tryptophan. There is a substantial body of evidence in the literature to support the role of ID0 in host defence against intracellular pathogens such as toxoplasma and chlamydia [14, 171. A recent study showed that the growth of extracellular organisms can be similarly inhibited by IDO-mediated L-tryptophan degradation in human cord blood macrophages [lo] . Bacteria such as GBS can cause sepsis and meningitis in neonates. There are good data to support the local extracellular depletion of L-tryptophan and, for example, low levels of L-tryptophan have been found in cerebrospinal fluid in infection [18] . Enterococci that adhere to the surface epithelium in the urinary tract, and even those that invade and penetrate this cell layer, may be prevented from proliferating by the depletion of the essential amino acid L-tryptophan by the uro-epithelial cells [16, 191 . This is solely a bacteriostatic effect, but may be sufficient to enable the professional phagocytes and effector cells to be recruited to kill the invading bacteria.
Enterococci are characterised by a greater resistance to antibiotics than other streptococci, they are constitutively resistant to cephalosporins and clindamicin and hibited by IFN-y in RT4 cells. Xfferent enterococcal isolates as shown in Table 1 reported [ 81. Multiresistant bacteria have a major impact on the morbidity and mortality of hospitalised patients and are also a major cause of increased medical costs [22] . VRE can be isolated from both hospitalised patients and from stools of healthy individuals. In a subgroup of immunosuppressed hospitalised patients, e.g., those undergoing cancer chemotherapy or transplantation, a higher incidence of VRE is observed [l] . This is probably a result of prolonged broad-spectrum antibiotic therapy exerting a selective pressure towards these organisms. Such patients with colonisation of the gut by VRE may also develop infections due to these organisms and it has been reported that bacteraemia with VRE has a poor prognosis [8] . As these patients also generally have a very low leucocyte counts or prolonged aplasia, the effector cells required to eradicate invading bacteria are missing. In this situation the stimulation of the epithelial cells by IF"-y may play a deciding role in the local control of infection, thereby preventing dissemination and bacteraemia. This is perhaps especially true in the subepithelial milieu, as the integrity of the epithelial surface is often reduced by chemotherapy, thus enabling the bacteria to penetrate to the subepithelial tissue more easily. In circumstances such as therapy-induced aplasia, effective treatment of infections with bactericidal antibiotics is a cornerstone of successful management; however, the threat of multidrug resistant bacteria makes this extremely difficult. As colonisation by VRE appears to be far more frequent than dissemination, even in patients with very low leucocyte counts, it is tempting to speculate that growth inhibition caused by the IFN-y-induced ID0 depletion of L-tryptophan in non-professional immune cells (such as uro-epithelial cells as described here) does in fact have an effect on the local containment of infection, thus preventing bacteraemia and subsequent morbidity. This bacteriostatic effect exerted by nonprofessional phagocytes may represent an important defence system which contains the local numbers of bacteria and thereby prevents or slows down a possible disseminated infection.
